中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2015年
15期
2824-2827
,共4页
蒋建新%张先龙%金东旭%唐明杰%虞申%樊家珠%黄琪仁%张长青
蔣建新%張先龍%金東旭%唐明傑%虞申%樊傢珠%黃琪仁%張長青
장건신%장선룡%금동욱%당명걸%우신%번가주%황기인%장장청
骨关节炎,膝%WOMAC评分%Lysholm评分%胶原蛋白肽
骨關節炎,膝%WOMAC評分%Lysholm評分%膠原蛋白肽
골관절염,슬%WOMAC평분%Lysholm평분%효원단백태
Osteoarthritis,knee%WOMAC score%Lysholm score%Colagen peptide
目的:采用随机双盲、安慰剂对照的前瞻性研究,评估服用胶原蛋白肽Peptan对中老年女性膝骨关节炎患者的效果。方法100例膝骨关节炎患者随机分成两组,试验组服用胶原蛋白肽Peptan 8 g/d,安慰剂组服用麦芽糊精8 g/d,连续服用6个月。应用WOMAC评分和Lysholm评分来评估治疗前后骨关节疼痛和功能改善状况。结果(1)服用6个月Peptan组WOMAC评分(11.33±4.28)明显低于安慰剂组(15.00±3.45,P<0.001);Peptan组Lysholm评分(85.24±8.88)明显高于安慰剂组(79.73±9.62,P<0.001);(2)两组WOMAC评分和 Lysholm 评分治疗前后的差值具有明显统计学差异(P<0.001);(3)服用6个月Peptan组的临床效果(关节疼痛好转和功能恢复情况)明显优于安慰剂组(P<0.001)。结论口服胶原蛋白肽Peptan能有效地改善中老年膝骨关节炎女性患者的关节功能,缓解疼痛,改善生活质量。
目的:採用隨機雙盲、安慰劑對照的前瞻性研究,評估服用膠原蛋白肽Peptan對中老年女性膝骨關節炎患者的效果。方法100例膝骨關節炎患者隨機分成兩組,試驗組服用膠原蛋白肽Peptan 8 g/d,安慰劑組服用麥芽糊精8 g/d,連續服用6箇月。應用WOMAC評分和Lysholm評分來評估治療前後骨關節疼痛和功能改善狀況。結果(1)服用6箇月Peptan組WOMAC評分(11.33±4.28)明顯低于安慰劑組(15.00±3.45,P<0.001);Peptan組Lysholm評分(85.24±8.88)明顯高于安慰劑組(79.73±9.62,P<0.001);(2)兩組WOMAC評分和 Lysholm 評分治療前後的差值具有明顯統計學差異(P<0.001);(3)服用6箇月Peptan組的臨床效果(關節疼痛好轉和功能恢複情況)明顯優于安慰劑組(P<0.001)。結論口服膠原蛋白肽Peptan能有效地改善中老年膝骨關節炎女性患者的關節功能,緩解疼痛,改善生活質量。
목적:채용수궤쌍맹、안위제대조적전첨성연구,평고복용효원단백태Peptan대중노년녀성슬골관절염환자적효과。방법100례슬골관절염환자수궤분성량조,시험조복용효원단백태Peptan 8 g/d,안위제조복용맥아호정8 g/d,련속복용6개월。응용WOMAC평분화Lysholm평분래평고치료전후골관절동통화공능개선상황。결과(1)복용6개월Peptan조WOMAC평분(11.33±4.28)명현저우안위제조(15.00±3.45,P<0.001);Peptan조Lysholm평분(85.24±8.88)명현고우안위제조(79.73±9.62,P<0.001);(2)량조WOMAC평분화 Lysholm 평분치료전후적차치구유명현통계학차이(P<0.001);(3)복용6개월Peptan조적림상효과(관절동통호전화공능회복정황)명현우우안위제조(P<0.001)。결론구복효원단백태Peptan능유효지개선중노년슬골관절염녀성환자적관절공능,완해동통,개선생활질량。
Objective Using a double-blind, randomized, placebo-controled study for evaluating effectivity of oral Peptan colagen peptides treatment in female patients with knee osteoarthritis (OA).Methods100 patients were randomly assigned to two groups, respectively taking Peptan? collagen peptides (CP) 8 g (n=50) or placebo (n=50) daily for 6 months. Each subject was evaluated for knee joint pain and function by using the standard tools (WOMAC scores and Lysholm scores). Results(1)CP groupvs. placebo group, WOMAC scores were lower (11.33±4.28vs. 15.00±3.45), and Lysholm scores were higher (85.24±8.88vs. 79.73±9.62) for 6 months (P<0.001); (2)The difference of WOMAC score and Lysholm score of post- and pre-study between CP group and placebo group was statisticaly significant (P<0.001); (3)The proportion of clinical effect was also found significant difference between the placebo group and the CP group for 6 months (P<0.001).Conclusion Oral Peptan colagen peptides can effectively improve patients’ knee osteoarthritis function, reduce joint pain and improve the quality of life.